Feedback
We would very much appreciate any thoughts you may have about OpenCME and how it could be made more useful for physicians like you.
CME Activity
Interpreting New Data on Leukemia and Myeloid Disorders: From Novel Treatment to Future Directions in Care
Accredited by
University of New Mexico Health Sciences Center, School of Medicine
View Activity Materials
Activity Details
| Credit Types: | CME |
| Credit Amount: | 0.5 Credits |
| Release Date: | 2012-Jan-20 |
| Expiration Date: | 2013-Jan-19 |
| Estimated Time for Completion: | 30 minutes |
| Registration Required: | No |
| Cost: | Free |
Program Description & Educational Objectives
This activity provides hematologists and hematologist-oncologists with a succinct summary of recent clinical trial data related to the treatment of leukemia and myeloid disorders, including data presented at the 2011 American Society of Clinical Oncology Annual Meeting (ASCO 2011) and 2011 American Society of Hematology Annual Meeting (ASH 2011).
Upon completion of this activity, participants should be better able to:
- Demonstrate knowledge of recent, clinically relevant safety and efficacy data on targeted and epigenetic therapy, novel cytotoxics, and other innovative treatment strategies in acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS)
- Apply data on clinical, molecular, or genetic predictive/prognostic features in the care of patients with MDS or AML
Target Audience
This activity has been designed to meet the educational needs of hematologists, hematologist-oncologists, and other clinicians involved in the management of myelodysplasia or acute leukemia.
Requirements for Successful Completion
In order to receive credit, participants must view the activity and complete the post-activity evaluation. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-activity evaluation.
Media: Internet
Release and Expiration Dates: January 20, 2012 - January 19, 2013
Time to Complete: 30 minutes
Faculty & Disclosure / Conflict of Interest Policy
In accordance with ACCME requirements, the University of New Mexico Health Sciences Center, School of Medicine, has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced. The relationships were reviewed by UNM CME and conflicts of interest were resolved prior to the activity.
CME Reviewer
Elizabeth A. McGuire, MD
Associate Professor
Hematologic Malignancies
University of New Mexico Cancer Center
Albuquerque, NM
Elizabeth A. McGuire, MD, currently has no financial interests/relationships or affiliations in relation to this activity.
Content Director
Kathryn B. Charalambous, PhD
PVI, PeerView Institute for Medical Education
Kathryn B. Charalambous, PhD, currently has no financial interests/relationships or affiliations in relation to this activity.
Sponsorship, Credit & Support
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of New Mexico Health Sciences Center, School of Medicine and PVI, PeerView Institute for Medical Education. The University of New Mexico Health Sciences Center, School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of New Mexico Health Sciences Center, School of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This CME activity is jointly sponsored by the University of New Mexico Health Sciences Center, School of Medicine and PVI, PeerView Institute for Medical Education.
This activity is supported by an educational grant from 
Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.
Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
Search
Suggest a CME Activity
Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.
OpenCME for Publishers
Please use the form below if you would like to offer your website visitors high quality CME content by adding the OpenCME Widget to one or more of your pages.
